1. Home
  2. PLTK vs ZLAB Comparison

PLTK vs ZLAB Comparison

Compare PLTK & ZLAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PLTK
  • ZLAB
  • Stock Information
  • Founded
  • PLTK 2010
  • ZLAB 2013
  • Country
  • PLTK Israel
  • ZLAB China
  • Employees
  • PLTK N/A
  • ZLAB N/A
  • Industry
  • PLTK EDP Services
  • ZLAB Biotechnology: Pharmaceutical Preparations
  • Sector
  • PLTK Technology
  • ZLAB Health Care
  • Exchange
  • PLTK Nasdaq
  • ZLAB Nasdaq
  • Market Cap
  • PLTK 2.6B
  • ZLAB 3.0B
  • IPO Year
  • PLTK 2021
  • ZLAB 2017
  • Fundamental
  • Price
  • PLTK $7.00
  • ZLAB $26.05
  • Analyst Decision
  • PLTK Hold
  • ZLAB Strong Buy
  • Analyst Count
  • PLTK 10
  • ZLAB 3
  • Target Price
  • PLTK $8.80
  • ZLAB $55.00
  • AVG Volume (30 Days)
  • PLTK 937.1K
  • ZLAB 482.4K
  • Earning Date
  • PLTK 02-24-2025
  • ZLAB 02-25-2025
  • Dividend Yield
  • PLTK 5.71%
  • ZLAB N/A
  • EPS Growth
  • PLTK N/A
  • ZLAB N/A
  • EPS
  • PLTK 0.58
  • ZLAB N/A
  • Revenue
  • PLTK $2,536,900,000.00
  • ZLAB $355,748,000.00
  • Revenue This Year
  • PLTK N/A
  • ZLAB $49.04
  • Revenue Next Year
  • PLTK $4.29
  • ZLAB $46.70
  • P/E Ratio
  • PLTK $12.05
  • ZLAB N/A
  • Revenue Growth
  • PLTK N/A
  • ZLAB 35.01
  • 52 Week Low
  • PLTK $6.25
  • ZLAB $13.48
  • 52 Week High
  • PLTK $9.16
  • ZLAB $36.60
  • Technical
  • Relative Strength Index (RSI)
  • PLTK 41.89
  • ZLAB 50.14
  • Support Level
  • PLTK $6.64
  • ZLAB $23.82
  • Resistance Level
  • PLTK $7.03
  • ZLAB $25.64
  • Average True Range (ATR)
  • PLTK 0.21
  • ZLAB 1.24
  • MACD
  • PLTK 0.05
  • ZLAB 0.06
  • Stochastic Oscillator
  • PLTK 66.97
  • ZLAB 64.45

About PLTK Playtika Holding Corp.

Playtika Holding Corp is primarily engaged in developing mobile games. Some of its games include Board Kings, House of Fun, Poker Heat, Slotomania, and Bingo Blitz. The company has built live game operations services and a proprietary technology platform to support its portfolio of games. It primarily derives revenue from the sale of virtual items associated with online games. Geographically, the group has a business presence in the USA, EMEA, APAC and Other regions of which key revenue is derived from the USA. It offers both Mobile and Web-based platforms.

About ZLAB Zai Lab Limited

Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. The pipeline of proprietary drug candidates of the company includes ZL-2306 for treatments across multiple solid tumor types including ovarian and certain types of breast and lung cancers; ZL-2401 which is an antibiotic in a new class of tetracycline derivatives; and ZL-2301 is an oral, small molecule which targets HCC.

Share on Social Networks: